« Previous
Next »
Brachytherapy
Volume 8, Issue 1
, Pages 19-25
, January 2009
Late chest wall toxicity after MammoSite® breast brachytherapy
References
- Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of randomized trials. Lancet. 2005;366:2087–2106
- Long-term outcome following breast-conserving surgery and radiation therapy. Int J Radiat Oncol Biol Phys. 1995;33:245
- Initial dosimetric experience using simple three-dimensional conformal external-beam accelerated partial-breast irradiation. Int J Radiat Oncol Biol Phys. 2006;64:1092
- Intraoperative radiation therapy with electrons (ELIOT) in early stage breast cancer. Breast. 2003;12:483
- Phase II trial of brachytherapy alone after lumpectomy for select breast cancer: toxicity analysis of RTOG 95-17. Int J Radiat Oncol Biol Phys. 2006;65:45
- Local resection and brachytherapy confined to the lumpectomy site for early breast cancer: a pilot study. J Surg Oncol. 1997;65:263–267
- Partial breast brachytherapy after lumpectomy: low-dose-rate and high-dose-rate experience. Int J Radiat Oncol Biol Phys. 2003;56:681–689
- Predictors of cosmetic outcome following MammoSite® breast brachytherapy: a single-institution experience of 100 patients with two years of follow-up. Int J Radiat Oncol Biol Phys. 2007;68:354–358
- Accelerated partial breast irradiation using MammoSite® brachytherapy: a multidisciplinary approach to breast-conservation therapy. Comm Oncol. 2005;2:477–482
- Acute complications of MammoSite® brachytherapy: a single institution's initial clinical experience. Int J Radiat Oncol Biol Phys. 2005;61:169–174
- Clinical experience with the MammoSite® radiation therapy system for brachytherapy of breast cancer: results from an international phase II trial. Radiother Oncol. 2006;79:316–320
- . Technology insight: MammoSite®—a new device for delivering brachytherapy following breast-conserving therapy. Nature Clin Pract Oncol. 2007;4:190–196
- Preliminary results and evaluation of MammoSite® balloon brachytherapy for partial breast irradiation for pure ductal carcinoma in situ: a phase II clinical study. Am J Surg. 2006;192:427–433
- Initial outcomes for patients treated on the American Society of Breast Surgeons MammoSite® clinical trial for ductal carcinoma-in-situ of the breast. Ann Surg Oncol. 2006;13:967–976
- Initial clinical experience with the MammoSite® breast brachytherapy applicator in women with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys. 2003;55:289–293
- Chest wall dose in MammoSite® breast brachytherapy: radiobiologic estimations of late complication risk based on dose-volume considerations. Brachytherapy. 2006;4:259–263
- Long-term radiation complications following conservative surgery (CS) and radiation therapy (RT) in patients with early stage breast cancer. Int J Radiat Oncol Biol Phys. 1992;23:915–923
- Long-term complications associated with breast-conservation surgery and radiotherapy. An Surg Oncol. 2002;9:543–549
- . Mandibular osteoradionecrosis. J Clin Oncol. 2004;23:4867–4868
- . Radiobiology for the radiologist. Chapter 7 6th ed.. Philadelphia, PA: Lippincott Williams and Wilkins; 2006;106–115
- Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys. 1991;21:109–122
- . Radiobiology for the radiologist. Chapter 19 6th ed.. Philadelphia, PA: Lippincott Williams and Wilkins; 2006;327–348
PII: S1538-4721(08)00605-3
doi: 10.1016/j.brachy.2008.07.007
« Previous
Next »
Brachytherapy
Volume 8, Issue 1
, Pages 19-25
, January 2009
